| Literature DB >> 27087645 |
Woong-Suk Yang1, Sung Ryul Lee2, Yong Joon Jeong3, Dae Won Park3, Young Mi Cho3, Hae Mi Joo4, Inhye Kim3, Young-Bae Seu1, Eun-Hwa Sohn5, Se Chan Kang3.
Abstract
The antiallergic potential of Arctium lappa L. was investigated in Sprague-Dawley rats, ICR mice, and RBL-2H3 cells. Ethanol extract (90%) of A. lappa (ALE, 100 μg/mL) inhibited the degranulation rate by 52.9%, determined by the level of β-hexosaminidase. ALE suppressed passive cutaneous anaphylaxis (PCA) in rats and attenuated anaphylaxis and histamine release in mice. To identify the active compound of ALE, we subsequently fractionated and determined the level of β-hexosaminidase in all subfractions. Oleamide was identified as an active compound of ALE, which attenuated the secretion of histamine and the production of tumor necrosis factor (TNF)-α and interleukin-4 (IL-4) in cells treated with compound 48/80 or A23187/phorbol myristate acetate (PMA). Oleamide suppressed FcεRI-tyrosine kinase Lyn-mediated pathway, c-Jun N-terminal kinases (JNK/SAPK), and p38 mitogen-activated protein kinases (p38-MAPKs). These results showed that ALE and oleamide attenuated allergic reactions and should serve as a platform to search for compounds with antiallergic activity.Entities:
Keywords: Arctium lappa L; Lyn; RBL-2H3 cell; antiallergic; oleamide
Mesh:
Substances:
Year: 2016 PMID: 27087645 DOI: 10.1021/acs.jafc.6b00425
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279